Inhibition of growth of human hepatoma cells by dual-function antisense IL-6 oligonucleotides

被引:9
作者
Kumagai, N
Tsuchimoto, K
Tsunematsu, S
Toda, K
Takeuchi, O
Saito, H
Morizane, T
Tsuchiya, M
Ishii, H
机构
[1] Kitasato Inst Hosp, Res Ctr Liver Dis, Dept Internal Med, Minato Ku, Tokyo 1088642, Japan
[2] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan
关键词
hepatoma; interleukin-6; antisense oligonucleotide; growth inhibition;
D O I
10.1016/S1386-6346(01)00128-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular lineage cell lines (two hepatoma and Chang liver cell lines) were found to produce interleukin-6 (IL-6). As the human hepatoma cell line, HCC-M expresses mRNA for both IL-6 and IL-6 receptor. we examined the possibility that IL-6 acted as an autocrine growth factor for HCC-M cells using two IL-6 antisense oligonucleotides (AS-1 and AS-2 oligomers) which were synthesized from different regions of an IL-6 cDNA clone. Both IL-6 antisense oligonucleotides inhibited the growth of HCC-M cells within 48 h (% inhibition by AS-1 and AS-2 oligomers was 53 and 21%. respectively). Although inhibition of HCC-M cell growth induced by AS-2 oligomer was restored by addition of exogenous recombinant IL-6 (rIL-6), the inhibition of growth induced by AS-1 oligomer was not fully restored by exogenous rIL-6, implicating the involvement of a nonantisense mechanism associated with four contiguous guanosine residues in this sequence. The inhibitory effect of AS-2 oligomer was attenuated after 72 h (% inhibition was 8%), whereas the AS-1 oligomer-induced inhibition of growth was sustained beyond 72 h (% inhibition was 38-39%). Therefore, these dual-function oligonucleotides that act via both an antisense and nonantisense mechanism may be of potential therapeutic value against hepatoma. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 28 条
  • [1] ALEXANDER JJ, 1976, S AFR MED J, V50, P2124
  • [2] THE ANTIPROLIFERATIVE ACTIVITY OF C-MYB AND C-MYC ANTISENSE OLIGONUCLEOTIDES IN SMOOTH-MUSCLE CELLS IS CAUSED BY A NONANTISENSE MECHANISM
    BURGESS, TL
    FISHER, EF
    ROSS, SL
    BREADY, JV
    QIAN, YX
    BAYEWITCH, LA
    COHEN, AM
    HERRERA, CJ
    HU, SSF
    KRAMER, TB
    LOTT, FD
    MARTIN, FH
    PIERCE, GF
    SIMONET, L
    FARRELL, CL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) : 4051 - 4055
  • [3] CHANG RSM, 1954, P SOC EXP BIOL MED, V87, P440
  • [4] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [5] Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
    Cressman, DE
    Greenbaum, LE
    DeAngelis, RA
    Ciliberto, G
    Furth, EE
    Poli, V
    Taub, R
    [J]. SCIENCE, 1996, 274 (5291) : 1379 - 1383
  • [6] Production of macrophage colony-stimulating factor by murine liver in vivo
    Ezure, T
    Ishiwata, T
    Asano, G
    Tanaka, S
    Yokomuro, K
    [J]. CYTOKINE, 1997, 9 (01) : 53 - 58
  • [7] ABSENCE OF HELA-CELL CONTAMINATION IN 169 CELL LINES DERIVED FROM HUMAN TUMORS
    FOGH, J
    WRIGHT, WC
    LOVELESS, JD
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 58 (02) : 209 - 214
  • [8] Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI DOI 10.1007/978-1-4757-1647-4_5
  • [9] Interleukin 1 beta and phorbol ester induce tumour necrosis factor alpha production in a hepatic cell line (HepG2)
    Frede, S
    Fandrey, J
    Jelkmann, W
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1996, 431 (06): : 923 - 927
  • [10] INDUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY HUMAN HEPATOCYTES IN CHRONIC VIRAL-HEPATITIS
    GONZALEZAMARO, R
    GARCIAMONZON, C
    GARCIABUEY, L
    MORENOOTERO, R
    ALONSO, JL
    YAGUE, E
    PIVEL, JP
    LOPEZCABRERA, M
    FERNANDEZRUIZ, E
    SANCHEZMADRID, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) : 841 - 848